| Author | Villar, Livia M. | |
| Author | Melo, Maria M. M. de | |
| Author | Calado, Izabelle A. | |
| Author | Almeida, Adilson J. de | |
| Author | Lampe, Elisabeth | |
| Author | Gaspar, Ana M. C. | |
| Access date | 2018-12-26T13:48:40Z | |
| Available date | 2018-12-26T13:48:40Z | |
| Document date | 2009 | |
| Citation | VILLAR, Livia M. et al. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?. Hepatology, v.24,p.238-242, 2009. | pt_BR |
| ISSN | 0270-9139 | pt_BR |
| URI | https://www.arca.fiocruz.br/handle/icict/30773 | |
| Language | eng | pt_BR |
| Publisher | Wiley | pt_BR |
| Rights | restricted access | |
| Subject in Portuguese | Vìrus da Hepatite A | pt_BR |
| Subject in Portuguese | Vírus da Hepatite C | pt_BR |
| Subject in Portuguese | Vacinação | pt_BR |
| Title | Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus? | pt_BR |
| Type | Article | |
| DOI | 10.1111/j.1440-1746.2008.05575.x | |
| Abstract | Hepatitis A virus (HAV) superinfection is associated with a high risk of liver failure and death in patients with hepatitis C virus (HCV) infection. The aim of this study was to investigate the presence of serological and molecular HAV markers in a population of HCV-infected patients in order to determine a cost-effective strategy to vaccinate against HAV. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatites Virais. Rio de Janeiro, RJ, Brasil. | pt_BR |
| Affilliation | Laboratório Central de Saúde Pública do Estado de Pernambuco. PE, Brasil. | pt_BR |
| Affilliation | Laboratório Central de Saúde Pública do Estado de Pernambuco. PE, Brasil. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatites Virais. Rio de Janeiro, RJ, Brasil. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatiyes Virais. Rio de Janeiro, RJ, Brasil. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Tecnologia Viral. Rio de Janeiro, RJ, Brasil. | pt_BR |
| Subject | hepatitis A virus | pt_BR |
| Subject | hepatitis C virus | pt_BR |
| Subject | Vaccination | pt_BR |
| e-ISSN | 1527-3350 | |
| Embargo date | 2030-01-01 | |
| xmlui.metadata.dc.subject.ods | 03 Saúde e Bem-Estar | |
